IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BENJAMIN FRANKLIN ROY

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1013021492
CMS profile
136458
Location
COLUMBUS, GA

General Payments · PY2018–2024

$54,422.79

  • Reported across 269 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,361.67

73 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry GA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,361.67 73

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $226.51 13
ABBVIE INC. $217.96 15
Neurocrine BioSciences, Inc. $202.30 9
Indivior Inc. $159.78 6
Teva Pharmaceuticals USA, Inc. $157.17 9
Alkermes, Inc. $145.92 9
Vanda Pharmaceuticals Inc. $99.79 5
Janssen Pharmaceuticals, Inc $48.12 2
E.R. Squibb & Sons, L.L.C. $41.60 2
Otsuka America Pharmaceutical, Inc. $38.51 2
Axsome Therapeutics, Inc. $24.01 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $32,635.75 76
PY2019 $11,232.01 47
PY2020 $2,773.72 10
PY2021 $4,095.79 5
PY2022 $1,433.61 6
PY2023 $890.24 52
PY2024 $1,361.67 73

Payment records · PY2024 (73)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.18 01/19/2024 Food and Beverage Undisputed 01/23/2026 1105982041 CMS
ABBVIE INC. $14.52 03/01/2024 Food and Beverage Undisputed 01/23/2026 1105982043 CMS
ABBVIE INC. $18.76 03/08/2024 Food and Beverage Undisputed 01/23/2026 1105982045 CMS
ABBVIE INC. $16.17 03/27/2024 Food and Beverage Undisputed 01/23/2026 1105982047 CMS
ABBVIE INC. $15.17 04/09/2024 Food and Beverage Undisputed 01/23/2026 1105982049 CMS
ABBVIE INC. $19.66 05/07/2024 Food and Beverage Undisputed 01/23/2026 1105982051 CMS
ABBVIE INC. $13.59 05/21/2024 Food and Beverage Undisputed 01/23/2026 1105982053 CMS
ABBVIE INC. $13.29 05/29/2024 Food and Beverage Undisputed 01/23/2026 1105982055 CMS
ABBVIE INC. $23.27 06/17/2024 Food and Beverage Undisputed 01/23/2026 1105982057 CMS
ABBVIE INC. $16.84 08/01/2024 Food and Beverage Undisputed 01/23/2026 1105982059 CMS
ABBVIE INC. $1.54 09/24/2024 Food and Beverage Undisputed 01/23/2026 1105982061 CMS
ABBVIE INC. $11.69 10/03/2024 Food and Beverage Undisputed 01/23/2026 1105982063 CMS
ABBVIE INC. $15.20 10/07/2024 Food and Beverage Undisputed 01/23/2026 1105982065 CMS
ABBVIE INC. $0.74 10/07/2024 Food and Beverage Undisputed 01/23/2026 1105982067 CMS
ABBVIE INC. $17.34 10/22/2024 Food and Beverage Undisputed 01/23/2026 1105982069 CMS
Alkermes, Inc. $14.86 02/28/2024 Food and Beverage Undisputed 01/23/2026 1120585345 CMS
Alkermes, Inc. $16.25 03/11/2024 Food and Beverage Undisputed 01/23/2026 1120585349 CMS
Alkermes, Inc. $15.35 04/29/2024 Food and Beverage Undisputed 01/23/2026 1120585353 CMS
Alkermes, Inc. $15.07 07/02/2024 Food and Beverage Undisputed 01/23/2026 1120585357 CMS
Alkermes, Inc. $17.39 07/23/2024 Food and Beverage Undisputed 01/23/2026 1120585360 CMS
Alkermes, Inc. $18.32 08/27/2024 Food and Beverage Undisputed 01/23/2026 1120585364 CMS
Alkermes, Inc. $15.07 10/16/2024 Food and Beverage Undisputed 01/23/2026 1120585368 CMS
Alkermes, Inc. $15.07 10/17/2024 Food and Beverage Undisputed 01/23/2026 1120585373 CMS
Alkermes, Inc. $18.54 10/30/2024 Food and Beverage Undisputed 01/23/2026 1120585377 CMS
Axsome Therapeutics, Inc. $24.01 12/12/2024 Food and Beverage Undisputed 01/23/2026 1148267239 CMS
E.R. Squibb & Sons, L.L.C. $18.06 11/19/2024 Food and Beverage Undisputed 01/23/2026 1101231557 CMS
E.R. Squibb & Sons, L.L.C. $23.54 12/02/2024 Food and Beverage Undisputed 01/23/2026 1101231555 CMS
Indivior Inc. $24.51 01/09/2024 Food and Beverage Undisputed 01/23/2026 1144536988 CMS
Indivior Inc. $25.30 01/29/2024 Food and Beverage Undisputed 01/23/2026 1144536990 CMS
Indivior Inc. $20.99 02/06/2024 Food and Beverage Undisputed 01/23/2026 1144536992 CMS
Indivior Inc. $33.36 04/18/2024 Food and Beverage Undisputed 01/23/2026 1144536994 CMS
Indivior Inc. $22.70 06/06/2024 Food and Beverage Undisputed 01/23/2026 1144536996 CMS
Indivior Inc. $32.92 06/06/2024 Food and Beverage Undisputed 01/23/2026 1144536998 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.26 01/18/2024 Food and Beverage Undisputed 01/23/2026 1143310574 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.68 03/15/2024 Food and Beverage Undisputed 01/23/2026 1143310578 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.50 05/02/2024 Food and Beverage Undisputed 01/23/2026 1143310582 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.27 06/05/2024 Food and Beverage Undisputed 01/23/2026 1143310585 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.97 07/16/2024 Food and Beverage Undisputed 01/23/2026 1143310589 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $31.79 08/06/2024 Food and Beverage Undisputed 01/23/2026 1143310593 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.56 08/20/2024 Food and Beverage Undisputed 01/23/2026 1143310596 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.15 09/10/2024 Food and Beverage Undisputed 01/23/2026 1143310600 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.78 10/01/2024 Food and Beverage Undisputed 01/23/2026 1143310604 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.83 10/14/2024 Food and Beverage Undisputed 01/23/2026 1143310608 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.07 11/07/2024 Food and Beverage Undisputed 01/23/2026 1143310612 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.87 12/03/2024 Food and Beverage Undisputed 01/23/2026 1143310615 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.78 12/16/2024 Food and Beverage Undisputed 01/23/2026 1143310619 CMS
Janssen Pharmaceuticals, Inc $27.00 09/20/2024 Food and Beverage Undisputed 01/23/2026 1077990266 CMS
Janssen Pharmaceuticals, Inc $21.12 10/17/2024 Food and Beverage Undisputed 01/23/2026 1077990264 CMS
Neurocrine Biosciences, Inc. $20.94 01/13/2024 Food and Beverage Undisputed 01/23/2026 1150854878 CMS
Neurocrine Biosciences, Inc. $22.96 02/06/2024 Food and Beverage Undisputed 01/23/2026 1150846689 CMS
Neurocrine Biosciences, Inc. $23.72 03/09/2024 Food and Beverage Undisputed 01/23/2026 1150844044 CMS
Neurocrine Biosciences, Inc. $21.95 04/09/2024 Food and Beverage Undisputed 01/23/2026 1150851380 CMS
Neurocrine Biosciences, Inc. $21.78 05/10/2024 Food and Beverage Undisputed 01/23/2026 1150852194 CMS
Neurocrine Biosciences, Inc. $23.17 08/26/2024 Food and Beverage Undisputed 01/23/2026 1150846015 CMS
Neurocrine Biosciences, Inc. $21.33 09/23/2024 Food and Beverage Undisputed 01/23/2026 1150853653 CMS
Neurocrine Biosciences, Inc. $21.86 10/18/2024 Food and Beverage Undisputed 01/23/2026 1150851930 CMS
Neurocrine Biosciences, Inc. $24.59 12/06/2024 Food and Beverage Undisputed 01/23/2026 1150841218 CMS
Otsuka America Pharmaceutical, Inc. $15.55 04/02/2024 Food and Beverage Undisputed 01/23/2026 1118972892 CMS
Otsuka America Pharmaceutical, Inc. $22.96 08/20/2024 Food and Beverage Undisputed 01/23/2026 1118972894 CMS
Teva Pharmaceuticals USA, Inc. $20.68 01/17/2024 Food and Beverage Undisputed 01/23/2026 1151729319 CMS
Teva Pharmaceuticals USA, Inc. $7.74 01/23/2024 Food and Beverage Undisputed 01/23/2026 1151729321 CMS
Teva Pharmaceuticals USA, Inc. $19.65 03/12/2024 Food and Beverage Undisputed 01/23/2026 1151729343 CMS
Teva Pharmaceuticals USA, Inc. $12.25 04/08/2024 Food and Beverage Undisputed 01/23/2026 1151729365 CMS
Teva Pharmaceuticals USA, Inc. $22.26 04/16/2024 Food and Beverage Undisputed 01/23/2026 1151729367 CMS
Teva Pharmaceuticals USA, Inc. $26.73 05/15/2024 Food and Beverage Undisputed 01/23/2026 1151729379 CMS
Teva Pharmaceuticals USA, Inc. $21.33 07/10/2024 Food and Beverage Undisputed 01/23/2026 1151729407 CMS
Teva Pharmaceuticals USA, Inc. $8.19 11/11/2024 Food and Beverage Undisputed 01/23/2026 1151729441 CMS
Teva Pharmaceuticals USA, Inc. $18.34 11/15/2024 Food and Beverage Undisputed 01/23/2026 1151729443 CMS
Vanda Pharmaceuticals Inc. $22.04 07/11/2024 Food and Beverage Undisputed 01/23/2026 1133918605 CMS
Vanda Pharmaceuticals Inc. $19.12 08/15/2024 Food and Beverage Undisputed 01/23/2026 1133918607 CMS
Vanda Pharmaceuticals Inc. $18.09 09/04/2024 Food and Beverage Undisputed 01/23/2026 1133918609 CMS
Vanda Pharmaceuticals Inc. $22.62 10/22/2024 Food and Beverage Undisputed 01/23/2026 1133918611 CMS
Vanda Pharmaceuticals Inc. $17.92 12/05/2024 Food and Beverage Undisputed 01/23/2026 1133918613 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.